Natus Medical Announces Record Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/10/2026
- S&P 500, Dow futures attempt recovery ahead of inflation report
- Brent holds above $100 as tanker attacks dampen hopes for Hormuz traffic recovery
- JPMorgan upgrades Meta on AI models and agents, sees 'meaningful headroom'
- HSBC lifts Novartis, downgrades Amgen in biopharma catalyst review
- This is Morgan Stanley's only preferred sportswear stock
- S&P 500 ends down as oil tops $100 per barrel
- Trump promises $5,000 payout to U.S. adults if Republicans win election
- White House copper tariff plan stalls amid affordability concerns, sources say
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Rogers adds Sportsnet+ content to Xfinity TV packages for free
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
Roth Capital Raises Price Target Following Natus Medical's (BABY) 3Q Results
October 22, 2015 8:20 AM EDTRoth Capital reiterated a Buy rating on Natus Medical (NASDAQ: BABY), and raised the price target to $53.00 (from $51.00), following the company's 3Q15 earnings results. BABY continues to outperform expectations, with 3Q non-GAAP operating margin of 19.9%.
Analyst Chris Lewis commented, "We remain bullish on BABY... More
Natus Medical (BABY) Tops Q3 EPS by 1c
October 21, 2015 6:07 AM EDTNatus Medical (NASDAQ: BABY) reported Q3 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $94.6 million versus the consensus estimate of $93.7 million.
Natus Medical sees Q4 2015 EPS of $0.47-$0.49, versus the consensus of $0.48. Natus Medical sees Q4 2015... More
